{"id":"https://openalex.org/W3136696593","doi":"https://doi.org/10.1016/j.ejca.2021.01.056","title":"High levels of TNF\u03b1 in patients with COVID-19 refractory to tocilizumab","display_name":"High levels of TNF\u03b1 in patients with COVID-19 refractory to tocilizumab","publication_year":2021,"publication_date":"2021-03-20","ids":{"openalex":"https://openalex.org/W3136696593","doi":"https://doi.org/10.1016/j.ejca.2021.01.056","mag":"3136696593","pmid":"https://pubmed.ncbi.nlm.nih.gov/33848711","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7980142"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejca.2021.01.056","doi":"https://doi.org/10.1016/j.ejca.2021.01.056","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejca.2021.01.056","pdf_url":"http://www.ejcancer.com/article/S0959804921001672/pdf","source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3136696593"],"child_works_count":0,"type":"letter","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.ejcancer.com/article/S0959804921001672/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060675099","display_name":"Fran\u00e7ois\u2010Xavier Danlos","orcid":"https://orcid.org/0000-0003-1880-064X","observed_orcids":["https://orcid.org/0000-0003-1880-064X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F.X. Danlos","raw_affiliation_strings":["INSERM U1015, Gustave Roussy Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1015, Gustave Roussy Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090912576","display_name":"F\u00e9lix Ackermann","orcid":"https://orcid.org/0000-0001-7209-4892","observed_orcids":["https://orcid.org/0000-0001-7209-4892"]},"institutions":[{"id":"https://openalex.org/I4210156825","display_name":"H\u00f4pital Foch","ror":"https://ror.org/058td2q88","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210156825"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F. Ackermann","raw_affiliation_strings":["H\u00f4pital Foch, Suresnes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Foch, Suresnes, France","institution_ids":["https://openalex.org/I4210156825"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064537418","display_name":"Julien Rohmer","orcid":"https://orcid.org/0000-0002-3128-4187","observed_orcids":["https://orcid.org/0000-0002-3128-4187"]},"institutions":[{"id":"https://openalex.org/I4210156825","display_name":"H\u00f4pital Foch","ror":"https://ror.org/058td2q88","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210156825"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. Rohmer","raw_affiliation_strings":["H\u00f4pital Foch, Suresnes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Foch, Suresnes, France","institution_ids":["https://openalex.org/I4210156825"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038981809","display_name":"Mathilde Roumier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156825","display_name":"H\u00f4pital Foch","ror":"https://ror.org/058td2q88","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210156825"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Roumier","raw_affiliation_strings":["H\u00f4pital Foch, Suresnes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Foch, Suresnes, France","institution_ids":["https://openalex.org/I4210156825"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065206480","display_name":"Aur\u00e9lien Marabelle","orcid":"https://orcid.org/0000-0002-5816-3019","observed_orcids":["https://orcid.org/0000-0002-5816-3019"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"A. Marabelle","raw_affiliation_strings":["INSERM U1015, Gustave Roussy Villejuif, France; D\u00e9partement D'Innovation Th\u00e9rapeutique et D'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Universit\u00e9 Paris Saclay, Villejuif, France. Electronic address: Aurelien.marabelle@gustaveroussy.fr","D\u00e9partement D'Innovation Th\u00e9rapeutique et D'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Universit\u00e9 Paris Saclay, Villejuif, France","INSERM U1015, Gustave Roussy Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1015, Gustave Roussy Villejuif, France; D\u00e9partement D'Innovation Th\u00e9rapeutique et D'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Universit\u00e9 Paris Saclay, Villejuif, France. Electronic address: Aurelien.marabelle@gustaveroussy.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I2801843802"]},{"raw_affiliation_string":"D\u00e9partement D'Innovation Th\u00e9rapeutique et D'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Universit\u00e9 Paris Saclay, Villejuif, France","institution_ids":["https://openalex.org/I277688954","https://openalex.org/I2801843802"]},{"raw_affiliation_string":"INSERM U1015, Gustave Roussy Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082291642","display_name":"Jean\u2010Marie Michot","orcid":"https://orcid.org/0000-0003-3482-3331","observed_orcids":["https://orcid.org/0000-0003-3482-3331"]},"institutions":[{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J.M. Michot","raw_affiliation_strings":["D\u00e9partement D'Innovation Th\u00e9rapeutique et D'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Universit\u00e9 Paris Saclay, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement D'Innovation Th\u00e9rapeutique et D'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Universit\u00e9 Paris Saclay, Villejuif, France","institution_ids":["https://openalex.org/I277688954","https://openalex.org/I2801843802"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5065206480"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I2801843802"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"149","issue":null,"first_page":"102","last_page":"104"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9760000109672546},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.8500000238418579},{"id":"https://openalex.org/keywords/tocilizumab","display_name":"tocilizumab","score":0.9670000076293945},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.8339999914169312},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.8140000104904175},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.6169999837875366},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.9020000100135803},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.8180000185966492},{"id":"https://openalex.org/keywords/cytokine-storm","display_name":"cytokine storm","score":0.7210000157356262},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.6320000290870667},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.734000027179718}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7021896839141846},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.6003281474113464},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5333884358406067},{"id":"https://openalex.org/C83867959","wikidata":"https://www.wikidata.org/wiki/Q371467","display_name":"Scopus","level":3,"score":0.5125696659088135},{"id":"https://openalex.org/C2777178219","wikidata":"https://www.wikidata.org/wiki/Q425154","display_name":"Tocilizumab","level":3,"score":0.4998767375946045},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.4808284044265747},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4210891127586365},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.4190836548805237},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.24005895853042603},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.23125359416007996},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093485","descriptor_name":"COVID-19 Drug Treatment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ejca.2021.01.056","doi":"https://doi.org/10.1016/j.ejca.2021.01.056","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejca.2021.01.056","pdf_url":"http://www.ejcancer.com/article/S0959804921001672/pdf","source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:33848711","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33848711","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of cancer (Oxford, England : 1990)","raw_type":"Letter"},{"id":"pmh:oai:pubmedcentral.nih.gov:7980142","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7980142/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eur J Cancer","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1016/j.ejca.2021.01.056","doi":"https://doi.org/10.1016/j.ejca.2021.01.056","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejca.2021.01.056","pdf_url":"http://www.ejcancer.com/article/S0959804921001672/pdf","source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320317614","display_name":"Fondation Philanthropia","ror":"https://ror.org/039r6xj59"},{"id":"https://openalex.org/F4320324826","display_name":"Institut Gustave-Roussy","ror":"https://ror.org/0321g0743"},{"id":"https://openalex.org/F4320329302","display_name":"Fondation Gustave Roussy","ror":"https://ror.org/05rfnt234"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3136696593.pdf","grobid_xml":"https://content.openalex.org/works/W3136696593.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W3001118548","https://openalex.org/W3015861468","https://openalex.org/W3022187628","https://openalex.org/W3022381041","https://openalex.org/W3022970339","https://openalex.org/W3034858522","https://openalex.org/W3036398841","https://openalex.org/W3047168254","https://openalex.org/W3080981445","https://openalex.org/W6776567292"],"related_works":["https://openalex.org/W3013789297","https://openalex.org/W4360860138","https://openalex.org/W3208409862","https://openalex.org/W3037719485","https://openalex.org/W4211022879","https://openalex.org/W7202357435","https://openalex.org/W4285601127","https://openalex.org/W3082201689","https://openalex.org/W3126658767","https://openalex.org/W3162617777"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2021-03-29T00:00:00"}
